04/30/2024
1:14 PM | Galectin Therapeutics (Issuer)
Zordani Richard A. Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2024
12:27 PM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2024
10:37 AM | CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
04/09/2024
3:42 PM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
6:51 AM | Galectin Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/29/2024
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
11:50 AM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/16/2024
7:50 AM | CARSON BENJAMIN SR (Reporting)
Galectin Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/16/2024
10:23 AM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
7:07 AM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
7:41 AM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
10:42 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/01/2023
3:50 PM | CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
12/01/2023
3:38 PM | 10X Fund, L.P. (Filed by)
Galectin Therapeutics (Subject)
| Form SC 13D/A | |
12/01/2023
7:05 AM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2023
4:19 PM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
8:21 AM | Galectin Therapeutics (Filer)
| Form 8-K/A | |
11/13/2023
6:50 AM | Galectin Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2023
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2023
11:36 AM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4/A | |
10/16/2023
7:09 AM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
7:03 AM | Galectin Therapeutics (Filer)
| Form DEF 14A | |
10/06/2023
7:05 AM | Galectin Therapeutics (Filer)
| Form DEFA14A | |
10/06/2023
7:08 AM | Galectin Therapeutics (Filer)
| Form ARS | |
10/02/2023
6:43 AM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2023
1:03 PM | Galectin Therapeutics (Issuer)
Uihlein Richard E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
8:53 AM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
3:38 PM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/01/2023
6:16 AM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
6:51 AM | Galectin Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2023
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2023
3:14 PM | Galectin Therapeutics (Issuer)
Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/20/2023
6:40 AM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
7:02 AM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
6:48 AM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
6:50 AM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
6:53 AM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2023
6:47 AM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2023
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
6:50 AM | Galectin Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2023
8:42 AM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad) If you think AI is big, then you have got to check out something I call Imperium…
By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details |
